These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4205945)

  • 61. [Characteristics of the immunogenic properties of cholerogen-anatoxin according to gel precipitation reactions and quantity of reducing sugars].
    Dzhaparidze MN; Martens LA; Egorova VD; Karaeva LT; Derteva II
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):48-51. PubMed ID: 808056
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Improved protection against cholera in adult rabbits with a combined flagellar-toxoid vaccine.
    Resnick IG; Ford CW; Shackleford GM; Berry LJ
    Infect Immun; 1980 Nov; 30(2):375-80. PubMed ID: 7439983
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen].
    Dzhaparidze MN; Nikitina GP; Kulikova VL; Popov AA; Naumov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):70-4. PubMed ID: 6204471
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preparation and evaluation of chitosan nanoparticles containing CtxB antigen against Vibrio cholera.
    Tabrizi NM; Amani J; Ebrahimzadeh M; Nazarian S; Kazemi R; Almasian P
    Microb Pathog; 2018 Nov; 124():170-177. PubMed ID: 30138759
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A toxoid prepared from cholera toxin by iodination.
    Heneine IF; Lahmann WM; Rocha OA
    Braz J Med Biol Res; 1992; 25(9):913-7. PubMed ID: 1342838
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biochemistry of Vibrio cholerae Virulence I. Purification and Biochemical Properties of PF/Cholera Enterotoxin.
    Richardson SH; Evans DG; Feeley JC
    Infect Immun; 1970 Jun; 1(6):546-54. PubMed ID: 16557774
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats.
    Dreesman GR; Hollinger FB; McCombs RM; Melnick JL
    Infect Immun; 1972 Feb; 5(2):213-21. PubMed ID: 4635499
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The adjuvant effect of pertussis endotoxin protein in modulating the immune response to cholera toxoid in mice.
    Sultzer BM; Craig JP; Castagna R
    Dev Biol Stand; 1985; 61():225-32. PubMed ID: 2872108
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Simple method for purifying choleragenoid, the natural toxoid of Vibrio cholerae.
    Mekalanos JJ; Collier RJ; Romig WR
    Infect Immun; 1977 Jun; 16(3):789-95. PubMed ID: 892899
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model.
    Boustanshenas M; Bakhshi B; Ghorbani M
    J Appl Microbiol; 2013 Feb; 114(2):509-15. PubMed ID: 23082752
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of cholera enterotoxin on ion transport across isolated ileal mucosa.
    Field M; Fromm D; al-Awqati Q; Greenough WB
    J Clin Invest; 1972 Apr; 51(4):796-804. PubMed ID: 4335444
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Construction of a recombinant live oral vaccine from a non-toxigenic strain of Vibrio cholerae O1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model.
    Thungapathra M; Sharma C; Gupta N; Ghosh RK; Mukhopadhyay A; Koley H; Nair GB; Ghosh A
    Immunol Lett; 1999 Jun; 68(2-3):219-27. PubMed ID: 10424424
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
    Villeneuve S; Boutonnier A; Mulard LA; Fournier JM
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biological characteristics of Clostridium perfringens type A enterotoxin.
    Stark RL; Duncan CL
    Infect Immun; 1971 Aug; 4(2):89-96. PubMed ID: 4343403
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of enterotoxin purified from Clostridium perfringens type C.
    Skjelkvålé R; Duncan CL
    Infect Immun; 1975 May; 11(5):1061-8. PubMed ID: 164411
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Somatic O antigen relationship of Brucella and Vibrio cholerae.
    Feeley JC
    J Bacteriol; 1969 Sep; 99(3):645-9. PubMed ID: 5370272
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunity to cholera: relation of fraction II of type 2 cholera toxin to vibriocidal antibody.
    Kaur J; Burrows W
    J Bacteriol; 1969 May; 98(2):467-74. PubMed ID: 4977478
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Production of cholera-like enterotoxin by a Vibrio cholerae non-O1 strain isolated from the environment.
    Craig JP; Yamamoto K; Takeda Y; Miwatani T
    Infect Immun; 1981 Oct; 34(1):90-7. PubMed ID: 7298194
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Common protective antigen between Pseudomanas aeruginosa and Vibrio cholerae.
    Yamamoto A; Homma JY; Ghoda A; Ishihara T; Takeuchi S
    Jpn J Exp Med; 1979 Dec; 49(6):383-90. PubMed ID: 120454
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Composition and immunochemical properties of the cell surface proteins of Vibrio cholerae.
    Kabir S
    J Gen Microbiol; 1986 Aug; 132(8):2235-42. PubMed ID: 3794649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.